Icomoon Capital participated in writing the "White Paper on Innovation in China's Cardiovascular Medical Device Industry".

After 10 months, more than 20 online and offline discussions, spanning 14 provinces and cities, bringing together 53 units including medical institutions, engineering colleges, medical device enterprises, and investment institutions, and with the joint compilation of 65 experts. On November 18th, the first industry innovation white paper in the field of cardiovascular medical devices in China - "China Cardiovascular Medical Device Industry Innovation White Paper (2021)", led by the China Cardiovascular Doctor Innovation Club (CCI), was officially released at the 2021 Annual Conference of the National Clinical Research Center for Radiation and Therapy.

Ge Junbo, an academician of the Chinese Academy of Sciences, personally serves as the chairman of CCI and the president of the Innovation Academy. He said that under the new situation of innovation in the cardiovascular field, the domestic cardiovascular industry is in urgent need of an in - depth report that can integrate clinical practice and industry and span technology and capital. Therefore, in the first year of the "14th Five - Year Plan", summarizing and sorting out the history and path of cardiovascular medical device innovation from a clinical perspective and exploring the development direction of cardiovascular medical device innovation will help promote the overall innovation and development of the medical device field in China, break through the "bottleneck" technologies as soon as possible, and ultimately benefit more patients in the cardiovascular field

Academician Ge Junbo introduced the original intention of writing the white paper. Photos provided by the interviewee

"The greatest value of the white paper lies in that it analyzes the development trends of the cardiovascular medical device industry from the perspective of doctors and their clinical practices, and can provide more future development directions for clinicians and the cardiovascular medical device industry," Professor Shen Li from Zhongshan Hospital Affiliated to Fudan University and the secretary-general of the CCI Innovation Academy told reporters.
Today, cardiovascular diseases are the number one risk factor threatening people's health. However, China's cardiovascular medical devices still have deficiencies in original innovation capabilities, innovation system construction, core components, and key materials, and there is still a gap from achieving overall self - controllability of the industrial chain and meeting the health needs of the people. At the same time, the implementation of the centralized procurement policy has put forward new requirements and challenges for the innovation of cardiovascular medical devices. As an important area of research in the medical - related industries, there are numerous innovation studies on cardiovascular medical devices from the perspectives of industry and capital. However, there has not yet been a report that deconstructs the development of the cardiovascular medical device industry with the clinical perspective and clinical needs as the primary starting point.
The "China Cardiovascular Medical Device Industry Innovation White Paper (2021)" sorts out the path of device innovation with the diagnosis and treatment process as the main line; explores future development directions with innovation as the main axis; shows the panorama of innovation around the development context of devices; and plans the cardiovascular innovation path with systematic thinking

From left to right: Under the chairmanship of Deputy Dean Qian Juying, Academician Ge Junbo, Wang Xin, the Party secretary of Zhongshan Hospital, Fan Jia, the dean of Zhongshan Hospital, and Professor Liu Jianmin from Changhai Hospital jointly unveiled the press conference. Photo provided by the interviewee

Academician Ge Junbo said that the "White Paper on the Innovation of China's Cardiovascular Medical Device Industry (2021)" has sorted out the innovation and development context of cardiovascular medical devices, systematically presented the industry map of China's cardiovascular medical device industry, indicated the development stages and gaps in the sub - device fields. By summarizing the current situation of the innovation and development of cardiovascular medical devices and years of innovation practice experience, it analyzes the hot - spot directions of future cardiovascular innovation and the potential target markets, explores the innovation and development trends of cardiovascular medical devices. Finally, it makes the role of doctors in the innovation process of medical devices clearer, enhances the enthusiasm of medical staff to participate in innovation and transformation, promotes the mutual penetration, intersection and integration of medical and engineering disciplines, and stimulates more original innovations based on clinical needs.
Among them, Chapter 6 of the white paper, "Prospects for the Innovation of China's Cardiovascular Device Industry", was jointly written by Liu Yueling, the founder of Haoyue Capital, and her team. It has made a systematic and innovative analysis and outlook on China's cardiovascular market and industry

For the full article, please refer to the WeChat official account "CCI Cardiovascular Doctor Innovation Club" and the "White Paper on Innovation in China's Cardiovascular Medical Device Industry"